Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 10, 2017
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
Geoff Meacham Maintained (ALNY) at Hold with Increased Target to $70 on, Aug 10th, 2017
Geoff Meacham of Barclays, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $50 to $70 on, Aug 10th, 2017.
Geoff has made no other calls on ALNY in the last 4 months.
There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, 0 agree with Geoff's Rating of Hold.
This is the rating of the analyst that currently disagrees with Geoff
- Do Kim of "BMO Capital" Initiated at Buy and Held Target at $73 on, Monday, April 17th, 2017
Similar Stocks and Investing Articles
[ Fri, Aug 04th 2017
] - WOPRAI
[ Mon, Jul 10th 2017
] - WOPRAI
[ Thu, Oct 06th 2016
] - WOPRAI
[ Thu, May 19th 2016
] - WOPRAI
[ Mon, Jun 15th 2015
] - WOPRAI
[ Tue, May 26th 2015
] - WOPRAI
[ Wed, Apr 08th 2015
] - WOPRAI
[ Mon, Nov 17th 2014
] - WOPRAI
[ Thu, Oct 31st 2013
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI